UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C.

FORM D
OMB APPROVAL
OMB Number: 3235-0076
Estimated Average burden hours per response: 4.0
Notice of Exempt Offering of Securities


1. Issuer's Identity
CIK (Filer ID Number) Previous Name(s)  o None Entity Type
0000890821
AMERI Holdings, Inc.
SPATIALIZER AUDIO LABORATORIES INC
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 Enveric Biosciences, Inc.
Jurisdiction of Incorporation/Organization
DELAWARE
 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed  



2. Principal Place of Business and Contact Information
Name of Issuer  
 Enveric Biosciences, Inc.  
Street Address 1 Street Address 2
 4851 TAMIAMI TRAIL N, SUITE 200  
City State/Province/Country ZIP/Postal Code Phone No. of Issuer
 NAPLES  FLORIDA  34103  239-302-1707 



3. Related Persons
Last Name First Name Middle Name
Tucker, PhD Joseph
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  Chief Executive Officer and Director
Last Name First Name Middle Name
Johnson David
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  Chairman
Last Name First Name Middle Name
Ward Carter
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  Chief Financial Officer
Last Name First Name Middle Name
Kanubaddi Avani
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  President and Chief Operating Officer
 
Last Name First Name Middle Name
Kegler George
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   
Last Name First Name Middle Name
Mayer Sol
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   
Last Name First Name Middle Name
Dagher Dr. Bob
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  Chief Medical Officer
Last Name First Name Middle Name
Facchini, PhD Peter
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  Chief Innovation Officer
 
Last Name First Name Middle Name
Lind Dr. Douglas
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   
Last Name First Name Middle Name
Schabacker Dr. Marcus
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   
Last Name First Name Middle Name
Pasqualone Frank
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   
Last Name First Name Middle Name
O'Niel Bevin
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   
 
Last Name First Name Middle Name
Webb Michael D.
Street Address 1 Street Address 2
4851 Tamiami Trail N Suite 200
City State/Province/Country ZIP/Postal Code
Naples FLORIDA 34103
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
   
 


4. Industry Group
o Agriculture   Health Care o Retailing
  Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance   Technology
  o Insurance   o Hospitals & Physicians   o Computers
  o Investing   x Pharmaceuticals   o Telecommunications
  o Investment Banking   o Other Health Care   o Other Technology
  o Pooled Investment Fund

         Travel
  o Other Banking & Financial Services o Manufacturing   o Airlines & Airports
  Real Estate   o Lodging & Conventions
  o Commercial   o Tourism & Travel Services
  o Construction   o Other Travel
  o REITS & Finance o Other
  o Residential  
  o Other Real Estate  
o Business Services  
  Energy  
  o Coal Mining  
  o Electric Utilities  
  o Energy Conservation  
  o Environmental Services  
  o Oil & Gas  
  o Other Energy  


5. Issuer Size
Revenue Range Aggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale  2022-07-22 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
   


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary)  
  

11. Minimum Investment
Minimum investment accepted from any outside investor $ 0 USD

12. Sales Compensation
Recipient Recipient CRD Number o None
 H.C. Wainwright & Co., LLC  375
(Associated) Broker or Dealer x None (Associated) Broker or Dealer CRD Number x None
     
Street Address 1 Street Address 2
 430 Park Avenue  3rd Floor
City State/Province/Country ZIP/Postal Code
 New York  NEW YORK  10022
State(s) of Solicitation o All States o Foreign/Non-US
 FLORIDA
 NEW YORK
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 8617500 USD o Indefinite
Total Amount Sold $ 8617500 USD  
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
 Includes 625K shares (or pre-funded warrants) and warrants to buy up to 625K shares at $8.00 per share and warrant for 1 share; warrants to buy up to 375K shares exercise price $7.78/share; 70K placement agent warrants, exercise price $10.00/share.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
  
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 2


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions $ 790950 USD o Estimate
Finders' Fees $ 0 USD o Estimate
 
Clarification of Response (if Necessary)
 PA received the above cash fee (including certain expense reimbursement) and 70K PA warrants, exercise price $10.00/share (not included in above cash fee) in connection with private placement and a concurrent RD offering (not reported on this Form D).


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
  $ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  

Signature and Submission
Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.
Terms of Submission 
  In submitting this notice, each Issuer named above is:  
 
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, the information furnished to offerees.
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the Issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against it in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of:� (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).
  
 
  Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.
  For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer Signature Name of Signer Title Date
Enveric Biosciences, Inc. Carter Ward Carter Ward Chief Financial Officer 2022-08-05

Ameri (NASDAQ:AMRH)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more Ameri Charts.
Ameri (NASDAQ:AMRH)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more Ameri Charts.